Pupillometer Market Size, Share & Trends Analysis Report By Mobility (Table-top, Hand-held), By Type (Video, Digital), By End Use (Hospitals, Eye Clinics), By Application (Ophthalmology, Oncology), By Region, And Segment Forecasts, 2023 - 2030

Pupillometer Market Size & Trends

The global pupillometer market size was valued at USD 372.6 million in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 6.85% from 2023 to 2030. Pupillometry is used extensively used to measure the pupil dilation to understand various underlying conditions. Various imaging modalities such as MRI and CT have identified that changes in brain activity has a direct impact on pupil dilation. Thus, measuring pupil dilation helps in understanding cognitive processes at a deep level. On the other hand, individuals with depression, anxiety, Parkinson’s disease, and autism spectrum disorder have also shown abnormal pupillometry response towards the stimuli. Therefore, pupillometry helps in understanding the normal eye functionality of an individual along with the brain activity impacted by a disease.

Pupil dilation can help in offering clues to understand the lives of the people with neurological disorders. Pupillometry results help in determining the physiological treatment. Usage of pupillometer can be an effective option to understand the best possible treatment for an individual. This in turn is expected to improve diagnostic outcomes, thus increasing recovery rates. Furthermore, pupillometry can also be used with other systems or process to enhance diagnosis of neurological disease. Brain-computer-interaction (BCI) can be enhanced using pupil dilation study, as it will act as an additional signal to understand the neurological signals.

The COVID-19 pandemic had a negative impact on the pupillometer market. Factors such as worldwide lockdowns and restrictions laid down by the government, increased focus on COVID-19 infected patients and postponement of patient visits to the medical facilities to curb the spread of the virus resulted in drop in sales of pupillometer in 2020.

Advantages associated with pupillometry is resulting into its increasing adoption. Various critical care units such as neurocritical care, surgical intensive care, cardiac intensive care, medical intensive care, pediatric intensive care, trauma, and emergency department are adopting pupillometers. Frequent pupil evaluation is now becoming the protocol in critical care units. Pupil size and pupillary light reflex (PLR) is being used as a prognostic indicator and clinical parameter by various associations and centers.

The Brain Trauma Foundation and the American Association of Neurological Surgeons recommends the usage of pupillary light reflex for each eye as a prognostic parameter. Usage of this on patients with neurological injury helps in facilitating the measurement of pupil dynamics of the patients provided with prescribed medications such as sedatives, analgesics, and anesthetic agents. Various nursing associations provide training and knowledge regarding pupillometry as it is becoming the key assessment for neurological examination. The American Association of Critical-Care Nurses (AACN) has featured a new section on pupillometry, to guide nurses regarding automated pupillometer in its Procedure Manual for High Acuity, Progressive and Critical Care.

Mobility Insights

Based on mobility, the pupillometer market is segmented into table-top and hand-held. The table-top pupillometer held a higher market share and accounted for 55.1% share of the global revenue in 2022. Large number of pupillometer comes in combination with other devices such as keratometer, pachymeters, wavefront aberrometers, corneal topographers, and others. These combined pupillometers are mainly table-top pupillometers installed in various facilities such as hospitals. Market players such as HAAG-STREIT GROUP, Johnson & Johnson Vision, and SCHWIND eye-tech-solutions are developing combined table-top pupillometer devices.

Hand-held pupillometers segment is expected to grow at the fastest rate during the forecast period. Hand-held pupillometer allows the user to efficiently and accurately obtain the pupil image which can be helpful in diagnosing various neurological diseases such as Alzheimer's disease. Moreover, the easy mobility of the hand-held pupillometer is leading to its increasing development and adoption. NeurOptics is one of the leading players in the market that develop hand-held pupillometer for critical care as well as applied research. Additionally, companies such as Adaptica have come up with a combined hand-held device called 2WIN which includes pupillometry as a feature. The dynamic pupillometry (DP-App) which is an additional feature of the product helps in detecting the pupillary changes, pupil distance, and pupil size. Development of advanced hand-held pupillometer is expected to propel the overall segment growth during the forecast period.

Type Insights

Based on type, the global pupillometer is fragmented into video and digital segments. The video pupillometer segment held for the largest revenue share of 56.4% in 2022 and is expected to grow at a significant rate during the forecast period. Video pupillometer helps in capturing the entire activity of pupil dilation which helps in understanding the changes and reason for the same. NeurOptics, a company that deals in the science of pupillometry by developing innovative technologies to help clinicians in providing better patient care. The company has come up with various video pupillometers for critical care as well as applied research. NPi-200 pupillometer is a video pupillometer developed by NeurOptics for critical care. This product is equipped with infrared camera, processor, high-precision optics, and LED light source. The video feature of the product helps in capturing the changes in pupil size and its reactivity over time.

VIP-300 pupillometer, PLR-3000 pupillometer, and DP-2000 are also video pupillometers by NeurOptics which are used for applied research. Some of these video pupillometers are hand-held whereas some are tabletops. These devices store data of the pupil measurement which can later be played or recalled on a screen. This, in turn, helps in increasing efficiency of the clinicians in order to capture pupil movement, pupil size, and other changes in the pupil due to medication or disease. Additionally, the integrated systems by various market players such as Essilor and HAAG-STREIT, also includes video pupillometry in its products. LENSTAR LS 900 and APS by HAAG-STREIT and Wave Analyzer Medica (WAM) 700 by Essilor are a few of combined devices with video pupillometer.

Digital pupillometer segment is expected to experience the fastest growth rate during the forecast period. The digital pupillometer helps in accurate and rapid assessment of pupil size. This device captures several frames in a second and average the measurements to determine the pupil dilation. Digital pupillometer helps in capturing all the fluctuations happening in the pupillary response, which in turn enhances the detection of neurological diseases. Market players such as Essilor, Luneau Technology Group, Reichert Technologies have developed digital pupillometers for proper diagnosis.

End-use Insights

Hospitals segment held the largest revenue share of 49.6% in 2022 in terms of end-use owing to the increasing adoption of the pupillometer in the setting. Pupillometer developed by NeurOptics is adopted by 400 hospitals around the U.S., thus, contributing towards the growth of the segment. Additionally, the growing usage of pupillometer in critical care units is also expected to contribute towards the segment growth. NeurOptics pupillometer is used in various critical care units such as neurocritical care, medical intensive care, emergency department, and cardiac intensive care.

Others segment include research institutions, research centers, and education centers/associations. Research institutions and centers are conducting research to understand the efficiency and effectiveness of pupillometry in other applications such as oncology. On the other hand, since the adoption of pupillometry is increasing in the field of neurology, this, in turn, is driving education centers or associations to include it as one of the segments. The new Core Curriculum for Neuroscience Nursing by the American Association of Neuroscience Nurses (AANN) has included a section on automated pupillary assessment. This section talks about the usage of pupillometer to understand pupillary reactivity in an objective, consistent, and quantifiable way.

Application Insights

Based on application, the market is segmented into ophthalmology, neurology, oncology, and others. The ophthalmology segment held for the largest revenue share of 49.4% in 2022 owing to the growing usage of pupillometry for checking pupil dilation, which in turn, helps in assessing retinal diseases. Pupillary light reflex helps in assessing visual system functionality. Pupillometry identifies differences in the response of melanopsin and cone/rod photoreceptors to understand damage on the outer and inner retina. Additionally, the measurement of pupil size helps refractive surgeons in understanding the after-effects of LASIK surgery. Large pupils measured patients are likely to have increased post-LASIK visual disturbances in scotopic conditions. Therefore, increasing adoption of pupillometry in ophthalmic diagnostics is expected to enhance the overall segment growth.

Usage of pupillometry in the field of oncology is gradually increasing. Clinical trial studies are being conducted to understand the effectiveness and efficiency of pupillometry in oncology. Pupillometry for a brain tumor is in practice across various settings, whereas studies are being conducted to understand the depth of anesthesia using pupillometer for health conditions such as breast cancer, thyroid tumor, and stroke. Determination of pupil size, pupillary response, pupillary unrest, and other pupillary characteristics can be an indication of conditions such as head trauma, brain tumor, or stroke. Therefore, a growing number of studies regarding pupillometry in oncology is expected to contribute towards the segment growth during the forecast period.

Regional Insights

North America dominated the market and accounted for over 26.1% share of global revenue in 2022 owing to the increasing prevalence of vision-related problems and neurological disorders. Additionally, the adoption and installation of a pupillometer across various settings in the U.S. are expected to drive the overall market growth. Major market players such as NeurOptics is headquartered in the U.S. and is developing advanced pupillometer for enhanced diagnosis in the country. Moreover, the company is also researching about the usage of pupillometer in various critical care fields to increase its product reach for different health conditions.

The Asia Pacific is expected to grow at the fastest rate during the forecast period. The growing availability of pupillometer in the region through various online platforms and suppliers is expected to contribute towards the segment growth. Additionally, global market players such as NeurOptics, Johnson & Johnson Vision, and Konan Medical are providing a pupillometer through its subsidiaries. NeurOptics is providing its pupillometer through its distributors Hansraj Nayyar Medical India, IMI Co., and Neuroplus in India, Japan, and South Korea respectively. Furthermore, the presence of global players such as NIDEK has also increased the availability and accessibility of pupillometer in the region.

Europe is also expected to grow at a considerable rate during the forecast period. Major market players such as SCHWIND eye-tech-solutions, Luneau Technology Group, and HAAG-STREIT GROUP are in the region and are developing advanced digital as well as video pupillometers. Additionally, these market players are incorporating pupillometry in various other ophthalmic diagnostic devices, and hence are offering integrated products. These products are expected to replace traditional products, thus, boosting the market growth.

Key Companies & Market Share Insights

The key player that dominated the global market in 2022 are NeurOptics, Inc., Essilor Instruments USA, HAAG-STREIT GROUP, and SCHWIND eye-tech-solutions. These market players are developing digital and integrated pupillometers with advanced featured to be used for various clinical applications in critical care units. Additionally, companies such as brightlamp, Inc. is focusing on integrating advanced technology into pupillometry to provide easily accessible pupillometry through mobile. Some prominent players in the pupillometer market include:

• NeurOptics, Inc.

• Adaptica

• Essilor Instruments USA

• HAAG-STREIT GROUP

• Johnson & Johnson Vision

• Luneau Technology Group

• NIDEK CO., LTD. 

• Reichert Technologies

• SCHWIND eye-tech-solutions

• US Ophthalmic

• Konan Medical

• brightlamp, Inc.

Pupillometer Market Report Scope

Global Pupillometer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2017 to 2030. For the purpose of this study, Grand View Research has segmented the global pupillometer market report on the basis of mobility, type, end-use, application, and region:

• Mobility Outlook (Revenue, USD Million, 2017 - 2030)

  • Table-top

  • Hand-held

• Type Outlook (Revenue, USD Million, 2017 - 2030)

  • Video

  • Digital

• End-use Outlook (Revenue, USD Million, 2017 - 2030)

  • Hospitals

  • Eye Clinics

  • Others

• Application Outlook (Revenue, USD Million, 2017 - 2030)

  • Ophthalmology

  • Neurology

  • Oncology

  • Others

• Regional Outlook (Revenue, USD Million, 2017 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Switzerland

    • Norway

    • Poland

  • Asia Pacific

    • China

    • Japan

    • India

    • Thailand

    • South Korea

    • Indonesia

    • Australia

    • Hong Kong

    • Philippines

    • Malaysia

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait

    • Qatar